FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC
The US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of primary biliary ...
Read moreThe US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of primary biliary ...
Read moreGepotidacin, an investigational antibiotic, proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of ...
Read moreAEF0117, a first-in-class drug, has shown potential in treating cannabis use disorder (CUD) by inhibiting specific signals in cannabinoid receptors. ...
Read more© 2023 earth-news.info
..................................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....